About Antimicrobial Agents And Chemotherapy
- Home |
- About Antimicrobial Agents And Chemotherapy
The “International conference and expo on Antimicrobial Agents and Chemotherapy’, organised by Hilaris conference, will be held on October 11-12, 2022 in Brussels, Belgium-Webinar.For our two –day event, Antimicrobial Expo 2022 invites all emit scientists, medical health care professionals, researchers, academic and industry to share and seek knowledge on various aspects of Antimicrobial Agents and Chemotherapy.
The subject of Antimicrobial Expo 2022 will be ‘Exploring new boundaries in the field of chemotherapy and antimicrobial agents, The Antimicrobial Expo 2022 program will be expand and promote talks, as well as provide hope to members from a wide range of topics and themes, in order to establish the capability of networking and collaboration inside and beyond disciplines for advancement in the field of Antimicrobial Agents and Chemotherapy.
The Antimicrobial Expo 2022 is being hosted by Hilaris conference, which brings together prominent international researchers, scientists, academic scientists, industrial researchers, doctors, practitioners and other professionals. We cordially invite you to attend the Hillaris Conference and contribute your findings in the hopes of a brighter future. To achieve our vision of “join us as a Learner and Proceed as a Leader, ‘we seek the support of stakeholders.
Antimicrobial Expo 2022 will bring together internationally renowned microbiologists, oncologists, medical fields, scientists, public health experts, academic scientists, industrial researchers, and intellectuals to exchange their views and knowledge.
Antimicrobiology is the study and treatment of microorganisms, as well as the discipline of killing them. If a person is infected with microorganisms like bacteria, viruses, fungi, etc., they should take antimicrobial agents to cure the diseases like antibiotics, antimicrobial drugs, antiseptics, vaccines.
Why to Attend:
The main goal of Antimicrobial Expo 2022 is to create a platform that will bring together eminent scientists from around the world, including microbiologists, professional doctors, medical professionals, and pharmaceuticals, who will undoubtedly enrich our meeting by participating in Q&A sessions and discussing and learning about new innovations in antimicrobial research.
This meeting's major goal is to promote novel therapeutics and pharmaceuticals and assess current demand for antimicrobial drugs, equipment, and diagnostics, with a particular focus on innovative items that will be useful across the laboratories. Healthcare professionals from over 100 countries are expected to attend. The best time to start a new organisation and coordinate efforts is now.
Benefits of Attending:
The best place to jumpstart your journey into each of the world's domains.
89 percent of our meeting attendees are the primary contact for their lab's purchasing decisions.
During the event, 80 percent of the attendees visited our exhibitor corners 4-5 times.
Past exhibitor feedback reveals a slew of questions from meeting attendees.
Academic and business advancement for the organisation.
Medical colleges and Universities
Noble laureates in Health Care and Medicine
Researchers & scientists
Manufacturing of Medical Devices Companies
The antimicrobial additives market is expected to increase at a CAGR of 6.6 percent from USD 4.0 billion in 2021 to USD 5.5 billion in 2026. Antimicrobials are substances or materials infused with antimicrobial agents and additives that prevent infection and fever-causing microganisms such as bacteria, fungi, algae, yeasts, mildew, and other parasites from growing. Microorganisms that thrive on untreated particles generate discoloration, foul odours, and polymer breakdown. Antimicrobial chemicals prevent these germs from growing in the final product. Antimicrobial additions provide improved dimensional stability, heat and chemical resistance, and chemical stability. The antimicrobial additives market is divided into types (organic, inorganic), applications (plastic, paints & coatings, pulp & paper, others), and end-use industries (healthcare, packaging, and food).
Antibiotic usage is rising in poor and middle-income nations, pharmaceutical corporations are investing heavily in R&D, and the prevalence of infectious illnesses is rising. Antibiotic resistance and rising medication approval costs, on the other hand, are expected to slow market growth. On the contrary, market participants are projected to benefit from the identification of advanced candidate medicines and the release of novel combination medications to treat antibiotic-resistant microbial illnesses.
Antibiotics are antibiotics that fight bacterial illnesses and infections, on rare occasions, protozoan infections. They're also used to treat strep throat, urinary tract infections, sinus infections, pneumonia, skin infections, ear infections, and other illnesses. Antibiotics are classified in a variety of ways, the most popular of which is based on their chemical structures, range of activity, and mode of action. Healthcare providers are currently in great demand for beta lactam and beta lactamase inhibitor medicines.
TOP UNIVERSITES RELATED TO ANTI –MICROBIOLOGY (WORLD-WIDE):
Massachusetts institute of Technology
University of California
University of Oxford
University of Washington
University of Pennsylvania
Washington University in St. Louis
University of Melbourne
Imperial College London
Johns Hopkins University
University of Wisconsin
University of Texas Medical Branch
University of Queensland Australia
University of Hong Kong
University of Cambridge
University of Chicago
Related Associations and Societies:
International Society of Antimicrobial Chemotherapy (ISAC)
International journal of Antimicrobial Agents
American Society of Microbiology
National Center for Biotechnology Information
British Society for Antimicrobial Chemotherapy
Infectious Diseases Society of America
Infection Society Antimicrobial stewardship
Society of General Microbiology
Society of Industrial Microbiology
Antimicrobial Drug use and resistance in Europe